RxDoctor Payments Data

Darron Cutler, DO

Family Medicine · Waterloo, IANPI 1396853750

Payments from drug & device makers

$1,237in general payments, 2019–2025

Across 85 payments — averaging $14.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$224
  • Astellas Pharma US Inc$199
  • Novo Nordisk$132
  • Amgen$127
  • AstraZeneca$87
  • Novartis$67
  • plus $401 from 13 others

What the payments were for

  • Food & beverage$1,05785%
  • Education$18015%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,237 in reported general payments places this provider in the 80th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$75,549
Medicare patients
251
Services billed
670

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban168$53,704
JardianceEmpagliflozin84$26,719
LinzessLinaclotide33$19,964
VraylarCariprazine Hcl25$19,261
FanaptIloperidone17$19,239
MyrbetriqMirabegron35$8,897
Tresiba Flextouch U-100Insulin Degludec33$8,833
JanuviaSitagliptin Phosphate27$7,734
GemtesaVibegron30$7,361
Divalproex Sodium ErDivalproex Sodium77$7,291
Gabapentin320$6,827
LantusInsulin Glargine,hum.Rec.Anlog79$6,696
TrintellixVortioxetine Hydrobromide22$6,291
Divalproex Sodium83$6,113
FarxigaDapagliflozin Propanediol19$5,924

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$12$53,704168 claims
AbbVieLinzess, Vraylar$224$39,22458 claims
Boehringer IngelheimJardiance$15$26,71984 claims
Astellas Pharma US IncMyrbetriq, Veozah$199$14,35353 claims
AstraZenecaFarxiga, Symbicort$87$11,55343 claims
MerckJanuvia$26$7,73427 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$63$6,29122 claims
Lilly USA, LLCHumalog, Olanzapine$54$4,87679 claims
Johnson & JohnsonXarelto$23$3,66813 claims
Esperion Therapeutics, Inc.Nexlizet$14$3,15511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Waterloo

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →